Quality Care
The company will use the funds to expand its cloud-based automation platform for providers and pharmaceutical companies.
This marks the Australian company's expansion into Saudi's private health sector after cementing its presence in its public health system.
The South Korean company now plans to expand the application of its AI to diagnose other medical conditions, including heart and neurological disorders.
The company will use the funds to enter into strategic relationships with life sciences organizations focusing on oncology and specialty care.
Also, Lunit has completed its acquisition of breast screening AI company Volpara.
Also, Optiscan is working with Mayo Clinic to develop a digital endomicroscopic imaging system for robotic surgery.
The launch of the WayFinding platform comes just weeks after the company announced it secured $126 million in funding.
The organizations will codevelop an atrial fibrillation program that provides clinical decision support tools and patient coaching between clinical visits.
Sonio will remain an independent company following the acquisition.
The company's stock price dropped after it released its first-quarter earnings and lowered its full-year guidance despite an increase in revenue.